-Candlestick chart has a bullish engulfing pattern
-The volume suddenly came after 3h, there might be some news coming up tomorrow or this week at least, because it has been quiet for the major part of the day.
It's defenitely worth keeping an eye on it for tomorrow.
Posted by Danny12345 on :
This one is looking pretty again....Might turn around here..
Posted by Danny12345 on :
Check that chart out. Notice the last time it hit .075 in October it ran all the way to .0185. Today might have been bottom and should be looking to turn north soon.
Posted by ohio_trader on :
got in today at .08... this is ready for a run
Posted by Danny12345 on :
gapping a bit this morning
Posted by ohio_trader on :
52 week high .83 52 week low .075 ( as in right now)
o/s 1,050,000,000 market cap $83,160,000
this is older: 1/9/2007, but shows the potential, and when the dems win the whitehouse(which is highly likely, and not a political stance) this could go over $1.00 again
IMO .20 by the end of February
Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent
Stem Cell Innovations, Inc. (OTCBB:SCLL) announced today the issuance of a key patent covering human pluripotent stem cells in the United States. "The patent provides a broad blocking position for the pluripotent cells of interest to Stem Cell Innovations as it covers isolated human primordial germ cell derived pluripotent cells," said Stem Cell Innovations CEO Dr. James Kelly. "We believe that this is a fundamental patent in human stem cell biology and an important addition to our foundational IP." The patent was issued in the United States as U.S. Patent No. 7,153,684 and is licensed exclusively to Stem Cell Innovations.
Stem Cell Innovations is developing PluriCells(TM), a new human stem cell technology derived from primordial germ cells of fetal tissue. PluriCells are distinct from ES cells and are believed to be outside the competitive patents on human ES cells. Primordial germ cells are one of only two types of cells known to be able to produce any of the more than 200 cell types found in the human body. The primordial germ cells are the cells that eventually produce the sperm and the egg, passing the genome along to the next generation. Stem cell cultures generated from these cells are believed to have tremendous promise in advancing drug discovery and cell-based therapies for some of our most intractable health problems, such as neurodegenerative disease. Stem Cell Innovations is actively pursuing these applications, such as in the recently announced drug discovery program with the ALS Association.
About Stem Cell Innovations, Inc.
SCI is a cell biology company with facilities in Scotch Plains, NJ, Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells(TM), have the potential to aid in drug discovery, toxicology, and cell therapy. Stem Cell Innovations is in the process of making its patented pluripotent cell lines, which are eligible for federal funding in the U.S., widely available to universities and other not-for-profit institutions to rapidly advance stem cell research.
Stem Cell Innovations is positioned to become a leading provider of toxicology testing and discovery systems for the pharmaceutical, chemical, and nutraceutical industries around the world. The development of the proprietary PluriCell(TM) technology greatly expands the Company's currently marketed C3A human liver cell-based toxicology offerings.
PluriCells is a Trademark of Stem Cell Innovations, Inc.
Forward-Looking Statement
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Forward-Looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We use words such as "expects", "intends", "believes", "may", "will" and "anticipates" to indicate forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including, but not limited to, those risks and uncertainties detailed in the Company's periodic reports filed with the Securities and Exchange Commission. We caution that these risk factors may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict these new risk factors, nor can we assess the effect, if any, of the new risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ from those expressed or implied by these forward-looking statements.
If any one or more or these expectations and assumptions proves incorrect, actual results will likely differ materially from those contemplated by the forward-looking statements. Even if all of the foregoing assumptions and expectations prove correct, actual results may still differ materially from those expressed in the forward-looking statements as a result of factors we may not anticipate or that may be beyond our control. While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the difference could be significant. We do not undertake to update any forward-looking statements made by us, whether as a result of new information, future events or otherwise. You are cautioned.
Stem Cell Innovations, Inc. Dr. James H. Kelly, +1 281-679-7900 or Ivo Piest, +31 71 8010 (Europe) www.stemcellinnovations.com
*** do your own homework ***
Posted by ohio_trader on :
hey superman7 u get in this yet?
its going to be a nice ride up
Posted by ohio_trader on :
starting to move back up
Posted by Danny12345 on :
nice
Posted by ohio_trader on :
in the green, now time to really move up!
Posted by ohio_trader on :
this has been a buckin bronco the last 15 minutes from .076-.093 back to.079 now movin back up again, this seems ready....chart is strong, volatility is good with stock like this, could be a sign of a big price pop
Posted by Danny12345 on :
I am strapped in Posted by Danny12345 on :
once ARCA move on ask, then we will have some action...
Posted by ohio_trader on :
great entry point, at the 52 week low
chart looking good for a rebound, and shows the volatility in the last year....alot of movement up and down, now at the BOTTOM
market cap now still at $80 million on 52 week low, as most penny companies aren't worth $80 million ever!
this will rebound to .20 in the next few weeks, moves swiftly with buying prssure, the political arena and media has been alittle quiet on stem cell research lately, but it always makes it back to the fore front.....next time this happens this could easily push .50 again...look at the chart
this is a 1-3 month hold for a nice gainer, not a 1-2 day gainer flash in the pan...as many and most pennystocks are
***do your own homework****
Posted by bb money on :
Nice EOD close looking for more on Monday!
Posted by Fergy on :
Gapping!!
Posted by cactus33 on :
this thing has been trying to run for last three days, but NITE bidwhacks it. i still think it goes looking at the charts.
why does it always seem like i follow up on either prdponce or hedfe's posts, lol.. never fails.. lol
I got in at 8 flat, lets see what this baby can do.
Posted by cactus33 on :
hey rocket, thats my avg right too now pretty much, charts really look like they are at a bottom. surprised more people arent interested.. who cares, lol
jmho
Posted by bb money on :
Im in on this one,just looking at the chart and seeing that channeling pattern gives me confidence in this one.
Posted by Rocketmist on :
I ended up selling cepo at 6.5 to get this, cepo was flat-lining and the volume was pretty bad lol, its a healthy switch I think
Posted by cactus33 on :
its trying again, lets see what nite does??
Posted by cactus33 on :
this needs to get over .085 and hold, if it does it could be good imo..
Posted by cactus33 on :
NITE is just plain nasty on this one..
Posted by cactus33 on :
either NITE will hve to break into support, like its been doing since .20.. or back off to show this could go, and get some buying going. seems hard to believe they will power sell into the .07's at this level on charts, but all the bidwhacking has stopped people from taking a risk in the mid .08's.. seems like it always comes down to this BS, lol
jmho
Posted by cactus33 on :
uhh ohh, here comes nite..
Posted by cactus33 on :
yep, looks like some dilution issues here, lol
Posted by bb money on :
Screw NITE they have to let this go sometime!!
Posted by cactus33 on :
you'd think BB, charts are screaming oversold, seems like when at this point? never know, i got some more in this dip..
jmho
Posted by cactus33 on :
seems like other people like this stock too out there, nice to see. i had the wrong OS numbers, just learned its 1 billion OS,ammost positive about that.. that sucks, i thought it was smaller than that, but charts are screaming oversold so i'll stick with it. who knows with these pennies, lol
jmho
Posted by Danny12345 on :
It's probably gonna be a while before this one heading back to the .2 . I got all the time in the world lol.
Posted by cactus33 on :
now NITE on the bid, lol
Posted by cactus33 on :
if they see a bunch of sell orders under 7 they will drag it that low, i have a feeling they will try.. there are a bunch under 7.. ,,mm's marked it, lol
Posted by cactus33 on :
OK, NITE.. you done? lol
charts are screaming oversold, SPX due to tighten imo
hmm, scll needs some news to waken people up that this is a good stock, not off to the best start.
Posted by Rocketmist on :
Wow, when will people realize that every day it jumps up like 5-10% just from overnight trading, then people are bidding it down right away absolutely no point in selling this right now.
Posted by cactus33 on :
bloated pos just cant bounce, lol
Posted by cactus33 on :
this ones nasty, missed bottom, but its so oversold i'll hold in the red for now.. ouch, lol
Posted by cactus33 on :
how many shares does NITE have, wow.. talk about backing the brinks truck from .20 wtf.. they have to back off soon.. or do they??, lol
jmho
Posted by cactus33 on :
got some more at .06.. last buy for me until i see a turn, but charts just looked too oversold to me.
any opinions from the gallery on this one, lol
Posted by bb money on :
I was in this one not to long ago Cactus, but decided to bail when NITE wasn't letting up on it and I could see when it broke its support that it was going lower. Don't like the bloated OS on this one, but like all POS's they have to let it go sometime. Can't tell how low they are going to take this one though but the chart is screaming oversold and should bounce.
Posted by cactus33 on :
thanks bb
Posted by cactus33 on :
mm's have been spanked on this one and they are sitting on a ton of shares imo, the vol is insane lately.. i am gambling that mm's have had enough of the selling and will turn the tables.. we'll see
jmho
Posted by cactus33 on :
never in my life have, this nuch, enjoyed seeing arca on the bid, lol
Posted by cactus33 on :
that was quick, lol
Posted by cactus33 on :
how much of an A hole is NITE on this, freaking unreal..
Posted by cactus33 on :
i think the board of directors are sitting at the table handing the computer to one another taking turns bid whacking, lol.. ok.. now its time for CLYP.. BS, lol
Posted by cactus33 on :
seems to be holding, tough bottom to predict.
nerves of steel on this one, lol
Posted by cactus33 on :
I am in the process of helping these clueless clowns.. they have good intentions, but not smart about spreading word. been emailing back and forth.. they are a little slow, but i think news on the way, i'll call first thing in morning to follow up.
jmho
this was one email..
Hey,
Should we do something about this? How does one communicate with investors if we don't know who they are?
Jim
On Feb 7, 2007, at 9:51 AM,
> The following email has been generated by a contact form on your website: www.amphioxus.com. Reporting this email as spam will cause your site to be reported for spamming. > > First Name XXXXXXXXX > Email Address: XXXXXXX > Comments: Do you have an Investor relations dept? I am wondering if we will hear an update about the company soon. > > > > > >
James H. Kelly, PhD
President and CEO
Stem Cell Innovations/Amphioxus Cell Technologies, Inc.
Looks like Mare Chassman owns a **** a load of warrants with a strike price of .06 cents. As far as I can tell she owns almost 200 million shares.
Margie Chassman is married to David Blech. Mr. Blech disclaims beneficial ownership of these shares. Since 1980 Mr. Blech has been a founder of companies and venture capital investor in the biotechnology sector. His initial venture investment, Genetic Systems Corporation, which he helped found and served as treasurer and a member of the board of directors, was sold to Bristol Myers in 1986 for $294 million of Bristol Myers stock. Other companies he helped found include DNA Plant Technology, Celgene Corporation, Neurogen Corporation, Icos Corporation, Incyte Pharmaceuticals, Alexion Pharmaceuticals and Neurocrine Biosciences.
Posted by cactus33 on :
clawing its way back up..
Posted by cactus33 on :
now its going..
Posted by cactus33 on :
dang NITE again..
Posted by Rocketmist on :
I placed a limit order, hopefully it will get filled. Nice looking chart, hopefully this can bring me the stability my crazy speculation portfolio needs. Looking for a nice 15% ish outta this.
Posted by cactus33 on :
it rebounded from under .06 to almost 7 today, but those greedy F's Nite swept in and killed it AGAIN.., could of easily finished over .07.. greed sucks some times, lol.. i cashed out some shares i got at .06 on the flip when i saw nite being evil again. but am holding much more, still think it has life.
Stem Cell Innovations Seeks European Union Registration for Its in vitro Toxicology Suite 9:18a ET February 9, 2007 (Business Wire)
Stem Cell Innovations (SCI), Inc. (OTCBB: SCLL) announced today that the Company has submitted its ACTIVTox(R) in vitro toxicology suite to ECVAM to seek validation as an alternative to animal testing in the European Union. Toxicity testing in the pharmaceutical and chemical industries is often performed in rodents. The use of ACTIVTox would reduce the need for animals in clinical testing, saving pharmaceutical companies time and money.
ACTIVTox, SCI's proprietary highly characterized human liver cell system, is currently being used to accurately predict the response of the liver to a new drug compound. Chemists can then eliminate potential toxicity before entering clinical trials. ACTIVTox is reproducible, relevant to the human and compatible with modern high throughput drug discovery. In addition, ACTIVTox has broad application and can be used to examine toxicity in chemicals, nutraceuticals and cosmetics.
ECVAM was created by a Communication from the European Commission to the Council and the Parliament in October 1991, pointing to a requirement in Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes, which requires that the Commission and the Member States should actively support the development, validation and acceptance of methods which could reduce, refine or replace the use of laboratory animals.
"Obtaining ECVAM approval for ACTIVTox in Europe is part of SCI's strategy to become a leading provider of alternatives for animal experiments," said CEO Dr. James Kelly. "Using our proprietary human cell models in combination with our in depth biology expertise, we will be in an excellent position to rapidly broaden our portfolio with new in vitro tests that help to reduce the number of animals used in the pharmaceutical industry."
About Stem Cell Innovations, Inc.
SCI is a cell biology company with facilities in Scotch Plains, NJ, Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells(TM), have the potential to aid in drug discovery, toxicology, and cell therapy.
Stem Cell Innovations is positioned to become a leading provider of toxicology testing and discovery systems for the pharmaceutical, chemical, and nutraceutical industries around the world. The development of the proprietary PluriCell(TM) technology greatly expands the Company's currently marketed C3A human liver cell-based toxicology offerings.
Posted by cactus33 on :
why am i not surprised CLYP 7 ticks under everyone bid whacking.. some greedy f's own this, thats for sure
Posted by cactus33 on :
it should still finish over 7 by eod imo
Posted by cactus33 on :
wow, toxic selling here.. nasty
Posted by cactus33 on :
wow, red alert, lol
Posted by rcm62 on :
Been patiently watching and waiting. There's got to be a bottom somewhere. Right? Posted by Zeker on :
Red on news- scary. I like being scared- it means that I'm still alive...
Posted by cactus33 on :
went to a late lunch and this chit.. sucks.. im hoping it will pop from this.. huge vol on nothing but selling, just insane how toxic this is looking. mm's have a lot of shares on their hands here, we'll see what happens. no doubt Zeker, im scared too, lol.. i do not like this selling this low.. at least the vol is there.. geesh..
Posted by cactus33 on :
its ugly man, i was wrong about three bottoms on this, at this point im treading very carefuly. this selling has caught me off guard..
quote:Originally posted by rcm62: Been patiently watching and waiting. There's got to be a bottom somewhere. Right?
Posted by cactus33 on :
Posted by rcm62 on :
Bottom is probably somewhere around $.0001.
10 employees. No revenue. 1+ Bil shares Will concentrate elsewhere, therefore it will go up 200% Monday.
Industry : BiotechnologyEmployees : 10Exchange : OTC BB
Debt/Equity Ratio 3.21 Gross Margin NA Net Profit Margin -17153.85% Total Shares Outstanding 1.1 Bil Market Capitalization 54.74 Mil Earnings/Share -0.21 StockScouter Rating NA
Stem Cell Innovations, Inc. has a business relating to the use of the Company's C3A human liver cell line in the field of drug discovery and toxicology testing. The Company has not yet developed any substantial market for its primary products. Stem Cell Innovations' principal revenues have been contract research and testing and consulting services for other companies, which have historically been minimal.
Posted by cactus33 on :
10 employees. No revenue. 1+ Bil shares Will concentrate elsewhere, therefore it will go up 200% Monday.
I gotta give you some stars for that one, rmc- been there many times.
Posted by Rocketmist on :
Wow, that was un-expected. But I must say I like it even more. We got a RHOI on our hands?
Posted by rcm62 on :
This is like a train wreck for me. I can't quit watching it.
Bid - .056 Ask - .058
Gapper?
Posted by cactus33 on :
its trying again
Posted by cactus33 on :
gapping hard pre market
Posted by cactus33 on :
whew, what a relief so far.. NITE backing off, it still has to finish strong to mean anything, but i feel a little better today..
Posted by cactus33 on :
wow, what greed, lol
Posted by rcm62 on :
This things bouncing around like a ping pong ball!
Posted by cactus33 on :
looks like its on its way to 10 mil in vol.. big money has moved thru this lately, wow
Posted by cactus33 on :
can you imagine, they sre gonna let this close red today??, lol
Posted by cactus33 on :
still selling at these low levels, but tons of buying.. just crazy volume for a stock at this price, maybe somethings up? who knows..
Posted by cactus33 on :
wow, just topped 11 million
Posted by cactus33 on :
freaking red close, lmao.. unreal.. everlasting POS.
wait for them to gap it pre market i guess, thinking that is mm's strategy to deal with this toxic selling.. almost 13 mill in vol.. huge selling and huge buying.. dang
Posted by cactus33 on :
Editorial: Stem cell dollars flow But grant process is needlessly shrouded Published 12:00 am PST Monday, February 12, 2007 Story appeared in EDITORIALS section, Page B4
Print | E-Mail | Comments
California's stem cell research institute has received little attention of late, and agency officials probably prefer it that way. But while the media have been off covering sex scandals involving mayors and astronauts, the Institute for Regenerative Medicine has been quietly preparing, for the first time in its two-year history, to dispense millions of public dollars for embryonic stem cell research.
This week, on Thursday and Friday, the institute's oversight committee will meet in San Francisco to decide on roughly $24 million in grants for new stem cell researchers with innovative ideas. While that may be pocket change compared with the $3 billion that voters authorized when they endorsed Proposition 71 in 2004, this initial research funding is historic, and other grants totaling about $100 million will soon follow this year.
Taxpayers curious about how their money will be spent can go to the institute's Web site -- www.cirm.ca.gov/publicsummaries/PublicList.html -- to see the 30 scientific proposals recommended for funding. The site also includes 200 other projects that didn't make the cut, with summaries and scientific assessments -- some of them surprisingly blunt -- about each proposal.
Once the institute's oversight board makes its final decision this week, it will identify the names and affiliations of scientists receiving grants but not those who didn't receive funding. Some watchdog groups say the oversight board should disclose all names, but institute leaders say that might embarrass researchers and discourage them from applying for grants. They also note the National Institutes of Health don't disclose such information.
We have some questions about the stem cell institute's rationale, but our bigger concern is its procedures for reviewing proposals and selecting projects to fund.
Scientists from outside states do much of this review work, and are not required to publicly disclose their potential conflicts of interest. Undoubtedly, some of those scientists have outside consulting work, or personal relationships with researchers seeking funding, that could affect their grant decisions. Yet under the institute's shrouded procedures, it is impossible for anyone -- including researchers applying for grants -- to be assured that grant reviewers are recusing themselves at the proper times.
This lack of public disclosure is the single most glaring problem with the Institute for Regenerative Medicine. While it is momentous that California is now on the leading edge of financing embryonic stem cell research, the institute still hasn't adopted a transparent procedure for policing potential conflicts. Lawmakers, in this session of the Legislature, need to correct that.
Posted by cactus33 on :
some more DD..
February 12, 2007, 1:34PM EST U.S., U.K. to promote stem cell research By RYAN J. FOLEY
Story Tools order a reprint digg this save to del.icio.us MADISON, Wis.
Leaders of national embryonic stem cell banks in the United States and the United Kingdom met here, in the birthplace of the field, on Monday and pledged to work together to promote research.
Representatives of the two banks said they were discussing ways to more efficiently distribute each other's cells to scientists and new standards to improve the quality of cells available.
The discussion came as Wisconsin Gov. Jim Doyle and leaders of the National Stem Cell Bank in Madison hosted a U.K. delegation that included the director of the U.K. Stem Cell Bank and chairman of the U.K. oversight committee on stem cell research.
At a news conference, the leaders said they hoped the efforts were the beginning of a long partnership between the banks. While stem cell research is still in its early stages, scientists believe it may eventually lead to treatment and perhaps cures for diseases such as Parkinson's and juvenile diabetes.
"This is not about one side, one state or one country winning and one losing," Doyle said. "This is about a huge area of scientific research that is expanding rapidly around the world, that we in Wisconsin happen to find ourselves in a leadership position."
The government-funded U.K. bank opened in 2004 as a repository for stem cells derived from embryos and adults. Its American counterpart was created the following year at WiCell Research Institute, a nonprofit connected to the University of Wisconsin, under a federal contract.
The U.S. bank houses and distributes 13 of the 21 embryonic stem cell lines that can be used in federally funded research under President Bush's policy limiting support to lines created before 2001. Wisconsin researcher James Thomson isolated the first of those lines in 1998.
Stem cells are created in the first days after conception. Because they go on to form the body's tissues and cells, scientists say they could unlock the mystery of many diseases and one day lead to cures.
But some people oppose the research because days-old embryos -- usually leftover from fertility treatments -- are destroyed in the effort to isolate the cells.
The two banks said they would discuss international standards for how cells are ethically derived from human embryos and maintained.
"Our main focuses are very similar: we want to promote the research and the development of potential therapies in the future," said Glyn Stacey, director of the U.K. bank. "These are the kinds of issues we're talking about and trying to make appropriate cell lines available to researchers and for clinical trials as well."
Carl Gulbrandsen, president of WiCell, said the two would discuss joint distribution of each other's cell lines. His group has already reached distribution agreements with some overseas companies.
"Shipping stem cell lines overseas is no easy task, hoping they arrive, they are healthy and can be used," he said.
But even as the banks work together, U.K. and American scientists will be operating under very different restrictions. U.K. researchers are allowed to clone embryos to extract stem cells and can qualify for government funding for such work.
In the U.S., some states have outlawed therapeutic cloning. And while the new Democratic Congress is trying to loosen Bush's restrictions, no federal money is now available for cloning embryos or new stem cell lines.
Posted by cactus33 on :
so what tomorrow.. 20 million in vol.. with a gapper im A.M. geesh.. unreal, lol
Posted by cactus33 on :
news..
Stem Cell Innovations to Present Data at the Stem Cells World Congress That PluriCells(TM) Can Produce Cells Important in Cardiovascular Disease 8:00a ET February 13, 2007 (Business Wire)
Stem Cell Innovations, Inc., or "SCI" (OTCBB: SCLL) announced today that James H. Kelly, Ph.D, Chief Executive Officer of Stem Cell Innovations (SCI), Inc. will present data at the Stem Cells World Congress in San Diego describing further characterization and extension of SCI's PluriCell(TM) stem cell system. The Congress draws together experts from academia and industry to discuss progress in the stem cell arena. In particular, Dr. Kelly will describe the ability of PluriCells(TM) to become endothelial cells, the cells that line the arteries and which are central players in cardiovascular disease. Normal adults have few circulating endothelial precursors in their blood but increased levels have been shown in conditions associated with myocardial infarction and stroke. PluriCells(TM) can provide both a drug discovery platform and also a potential cell therapy for use in these conditions.
"We are excited by the data demonstrating the important role PluriCells(TM) may play in cardiovascular disease," Kelly said. "The recent issuance of our patent on human pluripotent cells derived from primordial germ cells gives us a dominant intellectual property position in one of the two known types of fully pluripotent stem cells. The development of the endothelial cells, in combination with the other cell types we have already demonstrated, increases our ability to exploit this powerful system for both drug discovery and cell therapy."
SCI is developing PluriCells(TM), a new human stem cell technology derived from primordial germ cells of fetal tissue. PluriCells(TM) are distinct from embryonic stem (ES) cells. Primordial germ cells are one of only two types of cells known to be able to produce all of the more than 200 cell types found in the human body. The primordial germ cells are the cells that eventually produce the sperm and the egg, passing the genome along to the next generation. Stem cell cultures generated from these cells are believed to have tremendous promise in advancing drug discovery and cell-based therapies for some of our most intractable health problems, such as neurodegenerative and cardiovascular disease.
About Stem Cell Innovations, Inc.
SCI is a cell biology company with facilities in Scotch Plains, NJ, Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells(TM), have the potential to aid in drug discovery, toxicology, and cell therapy.
Stem Cell Innovations is positioned to become a leading provider of toxicology testing and discovery systems for the pharmaceutical, chemical, and nutraceutical industries around the world. The development of the proprietary PluriCell(TM) technology greatly expands the Company's currently marketed C3A human liver cell-based toxicology offerings.
Posted by cactus33 on :
gapping before the bell once again..
Posted by cactus33 on :
"James Kelly" <jkelly*amphioxus.com> Add to Address Book Add Mobile Alert Subject: Stem Cell Innovations Date: feb. 06, 2007 Mr....
At the time of the merger that formed the company (Feb 14, 2006), we did a financing for shares at $0.03. The one year holding period for those shares expires on Feb 14. This information is in our SEC filings. While I have no real ability to know who exactly is selling, I presume that the anniversary of that date accounts for the recent increase in our volume.
I just wanted to assure you that there are no problems at the company. It is simply people who got in at a price and are now liquidating their position to take their money off the table. I expect that there will be more of this over the next weeks. It has no relation to our long term prospects.
Sincerely,
Jim Kelly
Posted by Fergy on :
Just when you think the bottom might be here I read your post. I have been on the sidelines with the trigger finger ready but I will hold off again I guess. I appreciate the info. cactus. I thought this was just about to go but with the dumping it is hard to foresee the price in the short term. It is so oversold!!
Posted by Fergy on :
Anyone think they might come out with good news to get the pps up for those selling their now tradeable shares?
Posted by cactus33 on :
a lot of the selling has been due to people anticipating big selling, that may not be the case.. i still think selling dries up soon, as crazy as that sounds i guess, lol
Posted by cactus33 on :
finally, lets see it hold..
Posted by N-VEST-R on :
be patient, this will be back to .18 to .25 within 2 weeks
Posted by ohio_trader on :
technicals setting up for big rebound, buyers are coming back the last 3 days...last weeks sell volume was insane, appears majority of sells came from a few individuals/groups,rsi was driven way down
one mm signal that means a mm needs shares, he has a bad lot of orders he can not cover
hopefully this sign is for real!
Posted by cactus33 on :
looks like another 10 mill day, it needs to get over 6 and hold, then we are looking good imo
Posted by rcm62 on :
I finally entered this today. I like the chart. I will watch this close because it still scares the BEJESUS out of me. GLTA
Posted by cactus33 on :
lol, yea, it can be a roller coaster sometimes..
Posted by ohio_trader on :
looks like its moving back up right before close
up 32% now, watch it tommorrow!
Posted by cactus33 on :
yep, very nice.. above 6.. just what i wanted to see..
Posted by ohio_trader on :
closed up 30%, tommorrow should be interesting.....
Posted by rcm62 on :
That's what I like to see on Valentine's day.
Not going to be to greedy here. Will take a few coins if (when) it pops tomorrow am.
Sometimes it just takes patience.
Posted by N-VEST-R on :
gotta stay in until .15 atleast, will get there quickly now!
Posted by Danny12345 on :
yep I want at least .15 Posted by rcm62 on :
Wow. Getting further away from .15!
Gone to the hardware store to pick up some 16 penny nails.
Posted by cactus33 on :
im holding for now..
Posted by Danny12345 on :
anyone wanna bet? I say it will come back and close green today...... Posted by rcm62 on :
How late in the day will you entertain bets?
As a shareholder, I hope you are right, but it's gonna have to giddy-up to go green.
I really did not want to be holding this into Friday, but looks like that's what will happen. Posted by N-VEST-R on :
its ok.....gonna close .08 or higher friday.....hope.....!
Posted by argj00 on :
Ok bought my first penny shares, this one is going to .1
Posted by cactus33 on :
ohh man, this is your first one.. alright.. be careful, i am thinking about waving the white flag, lol.. its like a contest b/w mm's on who can crush support fastest.. not trying to panic you, i'll hold for now. but this selling is unreal..
jmho
Posted by cactus33 on :
nice MACD cross from a big low.. CMF rising, and we get this selling, if these greedy a holes would just back up a little we would be back to 8 easy.. its just out right greed..
welcome to the penny world, lol
Posted by rcm62 on :
Chart says GO! MM's say NO!
Posted by cactus33 on :
nice little come back here..
Posted by Rocketmist on :
I don't see how it can go that much lower now.
Posted by argj00 on :
I dont get it why would the market makers keep this down & how are they able to keep it down, & why would they want to keep it down?
Posted by Zeker on :
I don't think it's all the MMs' fault. Some of it seems to have to do with fear being fueled by rumors that no one can prove. It isn't really phasing me- I'd much rather add to a position in an oversold stock that I know will turn back up, than get caught buying into an overbought one that I knew was inevitably going to turn bad sooner or later.
Posted by cactus33 on :
1 billion OS and a 4 bill AS is the big problem i think..
a lot of shares out there, Im not going to add anymore until the selling calms down.. dont get greedy on this one imo..
good luck
jmho
Posted by N-VEST-R on :
relax, the selling is over and when it runs it will run fast!
Posted by Zeker on :
quote:Originally posted by N-VEST-R: relax, the selling is over and when it runs it will run fast!
Agreed- time is on our side (even if it means tying up some funds in the near-term).
Posted by N-VEST-R on :
Hey, it would be great if they all ran as soon as you drop in the funds but usually you gotta wait a bit for the really good ones!
This one will be very sweet, I believe! Good luck to all.
Posted by cactus33 on :
this baby loves to gap in the morning
Posted by rcm62 on :
I need a TA expert to tell me this is not what is happening.
A Pennant (Bearish) follows a steep, or nearly vertical fall in price, and consists of two converging trendlines that form a narrow, tapering flag shape. The Pennant shape generally appears as a horizontal shape, rather than one with a downtrend or uptrend.
Apart from its shape, the Pennant is similar in all respects to the Flag. The Pennant is also similar to the Symmetrical Triangle or Wedge continuation patterns however; the Pennant is typically shorter in duration and flies horizontally.
SCLL turning around now and about to jump!
Posted by Zeker on :
any minute now...
Posted by Zeker on :
There... it... goes........... oops... wrong way...
Posted by Zeker on :
if only red was green and green was red
Posted by N-VEST-R on :
Well, not the best day but if you take a close look at the chart you will see that this stock always goes back and forth just before a big run. So the way I see it, the run is coming soon and it's gonna be a big one too.
Posted by ohio_trader on :
good chance the run back up will start next week,
rebound written all over this one....
Posted by Zeker on :
I agree with you Ohio- the candles indicate that this one looks like it has found its near-term bottom and is looking for a way back up, which is significant because the previous reversal from buy to sell began back in mid-late January, and since then the PPS has fallen considerably. I'm not calling a reversal- only that based on the recent charts, IMO a near-term reversal is imminent.
Posted by N-VEST-R on :
Lets get a little piece of the run today!
Posted by N-VEST-R on :
Wow, what a sell off again.........hmmm starting to wonder if this one has to go lower before it pops............like maybe .03
![[Confused]](confused.gif)
![[Big Grin]](biggrin.gif)
![[Smile]](smile.gif)
![[Mad]](mad.gif)
![[Eek!]](eek.gif)
![[Frown]](frown.gif)